Goldman Sachs Group Inc Pacific Biosciences Of California, Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 509,427 shares of PACB stock, worth $820,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
509,427
Previous 484,741
5.09%
Holding current value
$820,177
Previous $601,000
8.49%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding PACB
# of Institutions
243Shares Held
190MCall Options Held
1.27MPut Options Held
601K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl30.9MShares$49.8 Million0.28% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$38 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$32.9 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.4MShares$26.4 Million0.0% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V810.7MShares$17.2 Million0.21% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $362M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...